151 related articles for article (PubMed ID: 21895881)
1. Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas.
You G; Huang L; Yang P; Zhang W; Yan W; Wang Y; Bao Z; Li S; Li S; Li G; Jiang T
Eur J Neurol; 2012 Feb; 19(2):298-306. PubMed ID: 21895881
[TBL] [Abstract][Full Text] [Related]
2. Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study.
Huang L; You G; Jiang T; Li G; Li S; Wang Z
J Neurol Sci; 2011 Mar; 302(1-2):63-7. PubMed ID: 21185573
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
4. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.
Huang L; Jiang T; Yuan F; Li GL; Cui Y; Liu EZ; Wang ZC
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):367-379. PubMed ID: 19019173
[TBL] [Abstract][Full Text] [Related]
5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Shuang L; Yingjun F; Qiao Z; Yanwu Y; Qing M
Seizure; 2013 Dec; 22(10):877-81. PubMed ID: 23992787
[TBL] [Abstract][Full Text] [Related]
7. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.
You G; Sha ZY; Yan W; Zhang W; Wang YZ; Li SW; Sang L; Wang Z; Li GL; Li SW; Song YJ; Kang CS; Jiang T
Neuro Oncol; 2012 Feb; 14(2):230-41. PubMed ID: 22187341
[TBL] [Abstract][Full Text] [Related]
8. Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
Yao PS; Zheng SF; Wang F; Kang DZ; Lin YX
J Neurosurg; 2018 Mar; 128(3):840-845. PubMed ID: 28387627
[TBL] [Abstract][Full Text] [Related]
9. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Stockhammer F; Thomale UW; Plotkin M; Hartmann C; Von Deimling A
J Neurosurg; 2007 Apr; 106(4):633-7. PubMed ID: 17432715
[TBL] [Abstract][Full Text] [Related]
10. Correlations between molecular profile and tumor location in Chinese patients with oligodendroglial tumors.
Huang L; Jiang T; Yuan F; Li GL; Liu EZ; Wang ZC
Clin Neurol Neurosurg; 2008 Dec; 110(10):1020-4. PubMed ID: 18845382
[TBL] [Abstract][Full Text] [Related]
11. Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis.
Zhang ZY; Chan AK; Ng HK; Ding XJ; Li YX; Shi ZF; Zhu W; Zhong P; Wang Y; Mao Y; Yao Y; Zhou LF
Int J Clin Exp Pathol; 2014; 7(12):8627-36. PubMed ID: 25674227
[TBL] [Abstract][Full Text] [Related]
12. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
Jansen NL; Schwartz C; Graute V; Eigenbrod S; Lutz J; Egensperger R; Pöpperl G; Kretzschmar HA; Cumming P; Bartenstein P; Tonn JC; Kreth FW; la Fougère C; Thon N
Neuro Oncol; 2012 Dec; 14(12):1473-80. PubMed ID: 23090986
[TBL] [Abstract][Full Text] [Related]
13. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
14. Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
Chang EF; Potts MB; Keles GE; Lamborn KR; Chang SM; Barbaro NM; Berger MS
J Neurosurg; 2008 Feb; 108(2):227-35. PubMed ID: 18240916
[TBL] [Abstract][Full Text] [Related]
15. Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.
Li S; Yan C; Huang L; Qiu X; Wang Z; Jiang T
Neuro Oncol; 2012 Jan; 14(1):109-16. PubMed ID: 22039037
[TBL] [Abstract][Full Text] [Related]
16. Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors.
Kim SH; Kim H; Kim TS
Acta Neuropathol; 2005 Jul; 110(1):27-38. PubMed ID: 15920661
[TBL] [Abstract][Full Text] [Related]
17. Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas.
Saito T; Muragaki Y; Maruyama T; Komori T; Tamura M; Nitta M; Tsuzuki S; Kawamata T
Brain Tumor Pathol; 2016 Jul; 33(3):175-82. PubMed ID: 26849373
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
19. Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.
Scheie D; Meling TR; Cvancarova M; Skullerud K; Mørk S; Lote K; Eide TJ; Helseth E; Beiske K
Neuro Oncol; 2011 Nov; 13(11):1225-33. PubMed ID: 21856683
[TBL] [Abstract][Full Text] [Related]
20. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
